Vladivostok, Vladivostok, Russian Federation
Vladivostok, Vladivostok, Russian Federation
The dynamics of parameters of cytokine status in patients with allergic rhinitis in view of efficiency of allergen-specific immunotherapy (ASIT) was studied in this work. 62 subjects with moderate persistent rhinitis at the age of 18-40 years old were included in the study. For specific diagnosis and treatment there we used standard allergens. ASIT was performed by the classical scheme. The concentrations of IL-4, IL-5, IL-6, IL-8 in the blood serum were measured by the enzyme immunoassay. A good or excellent effect of treatment with ASIT was achieved in 62.9% of cases, and satisfactory one in 37.1% of cases. The analysis of the dynamics of IL-4, IL-5, IL-6, IL-8 concentrations showed that the efficiency of ASIT in patients with allergic rhinitis depends on the ability of the immune system to activation by low doses of the allergen, quite fast suppression of proinflammatory cytokines induced by them, and active functioning of the system of anti-inflammatory cytokines.
persistent allergic rhinitis, allergen-specific immunotherapy, cytokines
1. Gurtovay M.N., Procopiev N.Y., Kolunin E.T., Gubin D.G., Durov A.M. Allergic rhinitis and bronchial asthma: the incidence, causes, and treatment (review of foreign literature) Mezhdunarodnyy zhurnal prikladnykh i fundamental’nykh issledovaniy 2016; 10(Pt1):29-37 (in Russian).
2. Gushchin I.S. Kurbacheva O.S. Allergy and allergen-specific immunotherapy. M.: Farmarus Print Media; 2010 (in Russian).
3. Drobik O.S. Nasunova A.Yu. Allergic rhinitis: allergist's point of view. Vestnik otorinolaringologii 2014; 2:82-85 (in Russian).
4. Serebrennikova S.N., Seminsky I.Zh. The role of cytokines in the inflammatory process (Part 1). Sibirskiy meditsinskiy zhurnal (Irkutsk) 2008; 81(6):5-8 (in Russian).
5. Andersson T.N., Ekman G.J., Grönlund H., Buentke E., Eriksson T.L., Scheynius A., Van Hage-Hamsten M., Gafvelin G. A novel adjuvant-allergen complex, CBP-rFel d 1, induces up-regulation of CD86 expression and enhances cytokine release by human dendritic cells in vitro. Immunology 2004; 113(2):253-259.
6. Arshad S.H. Primary prevention of asthma and allergy. J. Allergy Clin. Immunol. 2005; 116(1):3-14.
7. Brozek J.L., Bousquet J., Baena-Cagnani C.E., Bonini S., Canonica G.W., Casale T.B., van Wijk R.G., Ohta K., Zuberbier T., Schünemann H.J.; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision. J. Allergy Clin. Immunol. 2010; 126(3):466-476. doi:https://doi.org/10.1016/j.jaci.2010.06.047
8. Ciprandi G., Marseglia G.L., Tosca M.A. Allergen-specific immunotherapy: an update on im-munological mechanisms of action. Monaldi Arch. Chest. Dis. 2006; 65(1):34-37. doi:https://doi.org/10.4081/monaldi.2006.583
9. Fujisawa T., Nagao M., Hiraguchi Yu. Hosoki K., Tokuda R., Usui S., Masuda S., Shinoda M., Hashiguchi A., Yamaguchi M. Biomarkers for allergen immunotherapy in cedar pollinosis. Allergology Int. 2009; 58(2):163-170. doi:https://doi.org/10.2332/allergolint.09-RAI-0097
10. Grzela K., Grzela T., Lazarczyk M. et al. Korczak-Kowalska G., Wierzbicki P., Zawadzka-Krajewska A., Jozwiak J., Skopinski P. Influence of allergen-specific immunotherapy on IL-4-dependent IL-12 production by monocytes. Int. J. Mol. Med. 2002; 10(4):481-484.
11. Hayden M.L. Allergic rhinitis: diagnosis, treatment, and its effect on asthma. J. Asthma Allergy Educator 2010; 1:8-11.
12. Jutel M., Akdis M., Blaser K., Akdis C.A. Mechanisms of allergen specific immunotherapy - T- cell tolerance and more. Allergy 2006; 61(7): 796-807. doi:https://doi.org/10.1111/j.1398-9995.2006.01175.x
13. Moverare R., Rak S., Elfman L. Allergen-specific increase in (IL)-4 and IL-5 secreation from peripheral blood mononuclear cells during brich-pollen immunotherapy. Allergy 2007; 53(3):275-281.
14. Park H.S., Nahm D.H., Kim H.Y., Suh Y.J., Cho J.W., Kim S.S., Lee S.K., Jung K.S. Clinical and immunologic changes after allergen immunotherapy with Hop Japanese pollen. Ann. Allergy Asthma Immunol. 2001. 86(4):444-448.
15. Silny W., Czarnecka-Operacz M., Silny P. Effectiveness of specific immunotherapy in the treatment of children and you-ngsters suffering from atopic dermatitis. Part III. Serum concentrations of selected immunologic parameters. Wiad. Lek. 2005; 58(5-6):287-294.
